comparemela.com

Latest Breaking News On - Oncord biotech grey market premium - Page 1 : comparemela.com

Concord Biotech makes a strong debut at D-Street, lists at 21% premium at 900 05

The IPO of Concord Biotech was sold in the range of Rs 705-741 apiece, was overall subscribed 24.87 times and was sold between August 4 to August 8.

United statesNational stock exchangeConcord biotechDalal streetRakesh jhunjhunwala backed concord biotechConcord biotech listingConcord biotech listing priceOncord ipo biotech listingOncord biotech ipo listing priceOncord listingOncord listing priceOncord ipo listingOncord ipo listing priceOncord biotech grey market premiumOncord biotech ipo grey market premiumOncord grey market premium

Concord Biotech IPO to deliver a strong listing pop? Here s what grey market premium suggests

The IPO of Concord Biotech was sold in the range of Rs 705-741 apiece, was overall subscribed 24.87 times and was sold between August 4 to August 8.

Anubhuti mishraEquity research analyst at swastika investmartConcord biotechEquity research analystConcord biotech listingConcord biotech listing priceOncord ipo biotech listingOncord biotech ipo listing priceOncord listingOncord listing priceOncord ipo listingOncord ipo listing priceOncord biotech grey market premiumOncord biotech ipo grey market premiumOncord grey market premiumOncord ipo grey market premium

Concord Biotech IPO allotment: Check your application status & latest GMP

The IPO of Concord Biotech was sold in the range of Rs 705-741 apiece, was overall subscribed 24.87 times and was sold between August 4 to August 8

Concord biotechBombay stock exchangeLink intime india privateConcord biotech limitedDemat accountConcord biotech allotment statusOncord allotment statusConcord biotech ipo allotment statusOncord ipo allotment statusOncord biotech allotmentConcord biotech ipo allotmentOncord ipo allotmentOncord biotech grey market premiumOncord biotech ipo grey market premiumOncord grey market premiumOncord ipo grey market premium

vimarsana © 2020. All Rights Reserved.